Targeting inflammatory pathways in axial spondyloarthritis

by Daniel E. Furst, James S. Louie
Published 2019-06-01

The burning question: To use or not to use cyclophosphamide in systemic sclerosis

by Cosimo Bruni, Daniel E. Furst
Published 2020-10-01

Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

by Cosimo Bruni, Tracy Frech, Mirko Manetti, Francesca Wanda Rossi, Daniel E. Furst, Daniel E. Furst, Daniel E. Furst, Amato De Paulis, Felice Rivellese, Serena Guiducci, Serena Guiducci, Marco Matucci-Cerinic, Marco Matucci-Cerinic, Silvia Bellando-Randone, Silvia Bellando-Randone
Published 2018-09-01

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs

by William F. C. Rigby, Kathy Lampl, Jason M. Low, Daniel E. Furst
Published 2017-01-01

Examination of the Validity of Skin Ultrasound to Quantitate Skin Involvement for Multicenter Clinical Trials in Patients with Systemic Sclerosis (SSc): A Systematic Literature Rev...

by Omar M. Aly, Kevin L. Kafaja, Yossra A. Suliman, Daniel E. Furst
Published 2022-03-01

An International, Web-Based, Prospective Cohort Study to Determine Whether the Use of ACE Inhibitors prior to the Onset of Scleroderma Renal Crisis Is Associated with Worse Outc...

by Marie Hudson, Murray Baron, Ernest Lo, Joanna Weinfeld, Daniel E. Furst, Dinesh Khanna
Published 2010-01-01

Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease

by Yukai Wang, Xuezhen Xie, Shaoyu Zheng, Guangzhou Du, Shaoqi Chen, Weijin Zhang, Jinghua Zhuang, Jianqun Lin, Shijian Hu, Kedi Zheng, Angelina Mikish, Zhuangyong Xu, Guohong Zhang, Luna Gargani, Cosimo Bruni, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, Marco Matucci-Cerinic, Daniel E. Furst, Daniel E. Furst, Daniel E. Furst
Published 2022-12-01

Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data

by Paul Emery, Daniel E. Furst, Petra Kirchner, Simone Melega, Stuart Lacey, Patricia B. Lehane
Published 2019-11-01

Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial

by Roy Fleischmann, Daniel E. Furst, Erin Connolly-Strong, Jingyu Liu, Julie Zhu, Richard Brasington
Published 2020-03-01

Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project.

by Gil Amarilyo, Daniel E Furst, Jennifer M P Woo, Wen Li, Henning Bliddal, Robin Christensen, Simon Tarp
Published 2016-01-01

High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference

by Hongyan Li, Daniel E. Furst, Hongtao Jin, Chao Sun, Xiaoping Wang, Lin Yang, Jingjing He, Yanru Wang, Aijing Liu
Published 2018-08-01

Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiologi...

by Anton Wulf Christensen, Simon Tarp, Daniel E Furst, Anna Døssing, Kirstine Amris, Henning Bliddal, Peter C Taylor, Robin Christensen
Published 2015-01-01

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials...

by Andrea Rubbert-Roth, Daniel E. Furst, Stefano Fiore, Amy Praestgaard, Vivian Bykerk, Clifton O. Bingham, Christina Charles-Schoeman, Gerd Burmester
Published 2022-08-01

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis

by Philip J Mease, Daniel E Furst, Jeffrey R Lisse, Christophe Sapin, Kirstin Griffing, Sarah Ross, Paulo Reis, Aisha Vadhariya, Soumya Reddy
Published 2024-02-01

Economic and Health Care Resource Use Burden of Systemic Sclerosis

by Dinesh Khanna, Daniel E. Furst, Justin W. Li, Qian Meng, Yuan Yuan, Tamara Lesperance, Kenyatta Peoples, Farah Ali, Brian LaMoreaux, Stephanie D. Taylor
Published 2023-12-01

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

by Dinesh Khanna, Philip J. Clements, Elizabeth R. Volkmann, Holly Wilhalme, Chi-hong Tseng, Daniel E. Furst, Michael D. Roth, Oliver Distler, Donald P. Tashkin
Published 2019-01-01

Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung...

by Elizabeth R. Volkmann, Donald P. Tashkin, Holly LeClair, Michael D. Roth, Grace Kim, Jonathan Goldin, Philip J. Clements, Daniel E. Furst, Dinesh Khanna
Published 2020-06-01

Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials

by Ninna K. Senftleber, Sabrina M. Nielsen, Jens R. Andersen, Henning Bliddal, Simon Tarp, Lotte Lauritzen, Daniel E. Furst, Maria E. Suarez-Almazor, Anne Lyddiatt, Robin Christensen
Published 2017-01-01

Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II

by Elizabeth R. Volkmann, Virginia Steen, Ning Li, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Shervin Assassi, Dinesh Khanna, Grace‐Hyun J. Kim, Jonathan Goldin, Robert M. Elashoff, Donald P. Tashkin
Published 2021-01-01

Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis

by Robyn T. Domsic, Robin Pokrzywinski, Larissa Stassek, Wade W. Benton, Christa‐Lynn Vampola, Daniel E. Furst, Lorinda Chung, Virginia Steen, Maureen D. Mayes, Ami A. Shah, Jerry A. Molitor, Kelly Oliver, Vivek Nagaraja, Dinesh Khanna
Published 2023-03-01